Cargando…
P1409: PHASE-2 STUDY OF VARNIMCABTAGENE AUTOLEUCEL (IMN-003A) FIRST-IN-INDIA INDUSTRY CD19-DIRECTED CAR-T WITH FRACTIONATED INFUSIONS FOR PATIENTS WITH RELAPSED REFRACTORY B CELL MALIGNANCIES: IMAGINE STUDY
| Autores principales: | , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430606/ http://dx.doi.org/10.1097/01.HS9.0000972524.03326.b2 |
| _version_ | 1785091005678092288 |
|---|---|
| author | Malhotra, Pankaj Damodar, Sharat Bhat, Sunil Thirumalairaj, Raja Raj, Revathy Nayak, Akshatha Mallya, Pooja Joshi, Ravi Mb, Deepak Chougule, Sudarshan Dhar, Sudeshna Kumar Mg, Arun Arasu, Pallavi Ramulu Elluru, Sri Manzoor Akheel, Mohammed Kamat, Anil |
| author_facet | Malhotra, Pankaj Damodar, Sharat Bhat, Sunil Thirumalairaj, Raja Raj, Revathy Nayak, Akshatha Mallya, Pooja Joshi, Ravi Mb, Deepak Chougule, Sudarshan Dhar, Sudeshna Kumar Mg, Arun Arasu, Pallavi Ramulu Elluru, Sri Manzoor Akheel, Mohammed Kamat, Anil |
| author_sort | Malhotra, Pankaj |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10430606 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104306062023-08-17 P1409: PHASE-2 STUDY OF VARNIMCABTAGENE AUTOLEUCEL (IMN-003A) FIRST-IN-INDIA INDUSTRY CD19-DIRECTED CAR-T WITH FRACTIONATED INFUSIONS FOR PATIENTS WITH RELAPSED REFRACTORY B CELL MALIGNANCIES: IMAGINE STUDY Malhotra, Pankaj Damodar, Sharat Bhat, Sunil Thirumalairaj, Raja Raj, Revathy Nayak, Akshatha Mallya, Pooja Joshi, Ravi Mb, Deepak Chougule, Sudarshan Dhar, Sudeshna Kumar Mg, Arun Arasu, Pallavi Ramulu Elluru, Sri Manzoor Akheel, Mohammed Kamat, Anil Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10430606/ http://dx.doi.org/10.1097/01.HS9.0000972524.03326.b2 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Malhotra, Pankaj Damodar, Sharat Bhat, Sunil Thirumalairaj, Raja Raj, Revathy Nayak, Akshatha Mallya, Pooja Joshi, Ravi Mb, Deepak Chougule, Sudarshan Dhar, Sudeshna Kumar Mg, Arun Arasu, Pallavi Ramulu Elluru, Sri Manzoor Akheel, Mohammed Kamat, Anil P1409: PHASE-2 STUDY OF VARNIMCABTAGENE AUTOLEUCEL (IMN-003A) FIRST-IN-INDIA INDUSTRY CD19-DIRECTED CAR-T WITH FRACTIONATED INFUSIONS FOR PATIENTS WITH RELAPSED REFRACTORY B CELL MALIGNANCIES: IMAGINE STUDY |
| title | P1409: PHASE-2 STUDY OF VARNIMCABTAGENE AUTOLEUCEL (IMN-003A) FIRST-IN-INDIA INDUSTRY CD19-DIRECTED CAR-T WITH FRACTIONATED INFUSIONS FOR PATIENTS WITH RELAPSED REFRACTORY B CELL MALIGNANCIES: IMAGINE STUDY |
| title_full | P1409: PHASE-2 STUDY OF VARNIMCABTAGENE AUTOLEUCEL (IMN-003A) FIRST-IN-INDIA INDUSTRY CD19-DIRECTED CAR-T WITH FRACTIONATED INFUSIONS FOR PATIENTS WITH RELAPSED REFRACTORY B CELL MALIGNANCIES: IMAGINE STUDY |
| title_fullStr | P1409: PHASE-2 STUDY OF VARNIMCABTAGENE AUTOLEUCEL (IMN-003A) FIRST-IN-INDIA INDUSTRY CD19-DIRECTED CAR-T WITH FRACTIONATED INFUSIONS FOR PATIENTS WITH RELAPSED REFRACTORY B CELL MALIGNANCIES: IMAGINE STUDY |
| title_full_unstemmed | P1409: PHASE-2 STUDY OF VARNIMCABTAGENE AUTOLEUCEL (IMN-003A) FIRST-IN-INDIA INDUSTRY CD19-DIRECTED CAR-T WITH FRACTIONATED INFUSIONS FOR PATIENTS WITH RELAPSED REFRACTORY B CELL MALIGNANCIES: IMAGINE STUDY |
| title_short | P1409: PHASE-2 STUDY OF VARNIMCABTAGENE AUTOLEUCEL (IMN-003A) FIRST-IN-INDIA INDUSTRY CD19-DIRECTED CAR-T WITH FRACTIONATED INFUSIONS FOR PATIENTS WITH RELAPSED REFRACTORY B CELL MALIGNANCIES: IMAGINE STUDY |
| title_sort | p1409: phase-2 study of varnimcabtagene autoleucel (imn-003a) first-in-india industry cd19-directed car-t with fractionated infusions for patients with relapsed refractory b cell malignancies: imagine study |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430606/ http://dx.doi.org/10.1097/01.HS9.0000972524.03326.b2 |
| work_keys_str_mv | AT malhotrapankaj p1409phase2studyofvarnimcabtageneautoleucelimn003afirstinindiaindustrycd19directedcartwithfractionatedinfusionsforpatientswithrelapsedrefractorybcellmalignanciesimaginestudy AT damodarsharat p1409phase2studyofvarnimcabtageneautoleucelimn003afirstinindiaindustrycd19directedcartwithfractionatedinfusionsforpatientswithrelapsedrefractorybcellmalignanciesimaginestudy AT bhatsunil p1409phase2studyofvarnimcabtageneautoleucelimn003afirstinindiaindustrycd19directedcartwithfractionatedinfusionsforpatientswithrelapsedrefractorybcellmalignanciesimaginestudy AT thirumalairajraja p1409phase2studyofvarnimcabtageneautoleucelimn003afirstinindiaindustrycd19directedcartwithfractionatedinfusionsforpatientswithrelapsedrefractorybcellmalignanciesimaginestudy AT rajrevathy p1409phase2studyofvarnimcabtageneautoleucelimn003afirstinindiaindustrycd19directedcartwithfractionatedinfusionsforpatientswithrelapsedrefractorybcellmalignanciesimaginestudy AT nayakakshatha p1409phase2studyofvarnimcabtageneautoleucelimn003afirstinindiaindustrycd19directedcartwithfractionatedinfusionsforpatientswithrelapsedrefractorybcellmalignanciesimaginestudy AT mallyapooja p1409phase2studyofvarnimcabtageneautoleucelimn003afirstinindiaindustrycd19directedcartwithfractionatedinfusionsforpatientswithrelapsedrefractorybcellmalignanciesimaginestudy AT joshiravi p1409phase2studyofvarnimcabtageneautoleucelimn003afirstinindiaindustrycd19directedcartwithfractionatedinfusionsforpatientswithrelapsedrefractorybcellmalignanciesimaginestudy AT mbdeepak p1409phase2studyofvarnimcabtageneautoleucelimn003afirstinindiaindustrycd19directedcartwithfractionatedinfusionsforpatientswithrelapsedrefractorybcellmalignanciesimaginestudy AT chougulesudarshan p1409phase2studyofvarnimcabtageneautoleucelimn003afirstinindiaindustrycd19directedcartwithfractionatedinfusionsforpatientswithrelapsedrefractorybcellmalignanciesimaginestudy AT dharsudeshna p1409phase2studyofvarnimcabtageneautoleucelimn003afirstinindiaindustrycd19directedcartwithfractionatedinfusionsforpatientswithrelapsedrefractorybcellmalignanciesimaginestudy AT kumarmgarun p1409phase2studyofvarnimcabtageneautoleucelimn003afirstinindiaindustrycd19directedcartwithfractionatedinfusionsforpatientswithrelapsedrefractorybcellmalignanciesimaginestudy AT arasupallavi p1409phase2studyofvarnimcabtageneautoleucelimn003afirstinindiaindustrycd19directedcartwithfractionatedinfusionsforpatientswithrelapsedrefractorybcellmalignanciesimaginestudy AT ramuluellurusri p1409phase2studyofvarnimcabtageneautoleucelimn003afirstinindiaindustrycd19directedcartwithfractionatedinfusionsforpatientswithrelapsedrefractorybcellmalignanciesimaginestudy AT manzoorakheelmohammed p1409phase2studyofvarnimcabtageneautoleucelimn003afirstinindiaindustrycd19directedcartwithfractionatedinfusionsforpatientswithrelapsedrefractorybcellmalignanciesimaginestudy AT kamatanil p1409phase2studyofvarnimcabtageneautoleucelimn003afirstinindiaindustrycd19directedcartwithfractionatedinfusionsforpatientswithrelapsedrefractorybcellmalignanciesimaginestudy |